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Abstract
Background The American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP) surgical risk
calculator (SRC) aims to help predict patient-specific risk for morbidity and mortality. The performance of the SRC among an
elderly population undergoing curative-intent hepatectomy for hepatocellular carcinoma (HCC) remains unknown.
Methods Patients > 70 years of age who underwent hepatectomy for HCC between 1998 and 2017 were identified using a multi-
institutional international database. To estimate the performance of SRC, 12 observed postoperative outcomes were compared
with median SRC-predicted risk, and C-statistics and Brier scores were calculated.
Results Among 500 patients, median age was 75 years (IQR 72–78). Most patients (n = 324, 64.8%) underwent a minor
hepatectomy, while 35.2% underwent a major hepatectomy. The observed incidence of venous thromboembolism (VTE)
(3.2%) and renal failure (RF) (4.4%) exceeded the median predicted risk (VTE, 1.8%; IQR 1.5–3.1 and RF, 1.0%; IQR 0.5–
2.0). In contrast, the observed incidence of 30-day readmission (7.0%) and non-home discharge (2.5%) was lower than median-
predicted risk (30-day readmission, 9.4%; IQR 7.4–12.8 and non-home discharge, 5.7%; IQR 3.3–11.7). Only 57.8% and 71.2%
of patients who experienced readmission (C-statistic, 0.578; 95%CI 0.468–0.688) or mortality (C-statistic, 0.712; 95%CI 0.508–
0.917) were correctly identified by the model.
Conclusion Among elderly patients undergoing hepatectomy for HCC, the SRC underestimated the risk of complications such as
VTE and RF, while being no better than chance in estimating the risk of readmission. The ACS SRC has limited clinical
applicability in estimating perioperative risk among elderly patients being considered for hepatic resection of HCC.
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Introduction
While representing only about 5% of all new cancer diagnoses
worldwide, hepatocellular carcinoma (HCC) is the third
leading cause of cancer-related mortality.1 In the USA, the
mortality rate associated with liver cancer has increased over
30% since 2002 and the highest mortality rate has been report-
ed among the elderly.2–4 An increasing life expectancy among
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the general population has resulted in a growing number of
elderly patients diagnosed with hepatic malignancies.5 For
many patients, hepatic resection remains the best chance for
cure.6 In light of medical advances and improvement in sur-
gical technique, surgical patient selection has expanded and a
greater number of complex patients—including older individ-
uals with a higher comorbidity burden—are offered surgical
resection.7 Thus, as the population continues to age, the pro-
portion of elderly patients being considered for surgical inter-
vention of a liver malignancy is expected to increase.
Concern exists, however, regarding the safety of hepatic
resection among older patients. Indeed, elderly patients have
more comorbidities and age-associated changes that can con-
tribute to postoperative morbidity and mortality after major
abdominal surgery.8–10 In fact, the rates of postoperative seri-
ous complications and mortality among older patients under-
going hepatopancreatobiliary (HPB) surgery have been re-
ported to be as high as 50% and 6%, respectively.11–15
Moreover, the development of severe postoperative complica-
tions may lead to a delay in return to home and receipt of
adjuvant therapies, which can result in worse overall
survival.16,17 As such, a thorough preoperative assessment of
morbidity and mortality risk is critical when counseling indi-
viduals, especially among elderly patients.
In that context, the American College of Surgeons (ACS)
developed the National Surgical Quality Improvement
Program (NSQIP) online surgical risk calculator (SRC) based
on data from over 3.8 million operations performed in 740
participating hospitals from 2012 to 2016. While risk calcula-
tors have been reported to be useful in predicting the risk of
myocardial infarction or coronary death, surgical prognostica-
tion has been challenging due to the differences between the
initial cohorts used to develop the tool and the Breal-world^
population.18,19 In fact, previous studies have reported a dis-
crepancy between predicted risk by the SRC and observed
outcomes among patients undergoing abdominal surgery.20,21
The performance of the ACSNSQIP SRC to predict outcomes
among elderly patients undergoing hepatectomy for HCC has,
however, not been assessed. As such, the objective of the
current study was to determine the accuracy of the ACS
NSQIP SRC to predict outcomes among elderly patients un-
dergoing curative-intent liver resection for HCC using an in-
ternational multi-institutional database.
Methods
Study Population and Data Collection
Patients 70 years of age or older who underwent curative-
intent hepatectomy for histologically proven HCC with be-
tween 1998 and 2017 were identified using an international
multi-institutional database (Fig. 1). Patients were enrolled
from one of 11 major institutions, including The Ohio State
University Wexner Medical Center, Columbus, OH, USA;
Yokohama City University School of Medicine, Yokohama,
Japan; University of Verona, Verona, Italy; Ospedale San
Raffaele, Milano, Italy; Curry Cabral Hospital, Lisbon,
Portugal; APHP, Beaujon Hospital, Clichy, France;
Westmead Hospital, Sydney, Australia; Stanford University,
Stanford, CA, USA; Fundeni Clinical Institute, Bucharest,
Romania; University of Ottawa, Ottawa, Canada; and The
University of Sydney, School of Medicine, Sydney,
Australia. Hepatectomywas identified using current procedur-
al terminology (CPT) codes (47,120, partial hepatectomy;
47,125, left hepatectomy; 47,130, right hepatectomy;
47,122, trisegmentectomy). Partial hepatectomy was catego-
rized as a minor hepatectomy, while left hepatectomy, right
hepatectomy, and trisegmentectomy were categorized as a
major hepatectomy. Patients who were less than 70 years of
age, who did not have curative-intent surgery, or had ablation
only were excluded. The study was approved by the
Institutional Review Boards of all participating institutions.
The ACS NSQIP calculator was accessed online at http://
riskcalculator.facs.org/ on November 29 and 30, 2018.
Individual patient data and respective CPT codes were
entered into the calculator. Using the ACS NSQIP
calculator, the incidence risk for the following 12 outcomes
were estimated: serious complication, any complication,
pneumonia, cardiac complication, surgical site infection
( SS I ) , u r i n a r y t r a c t i n f e c t i o n (UT I ) , v e n ou s
thromboembolism (VTE), renal failure, 30-day readmission,
reoperation, 30-day mortality, and non-home discharge.
Patient data required for calculation included procedure type,
age group, sex, functional status, emergency case, American
Society of Anesthesiologists (ASA) class, steroid use for
chronic condition, ascites within 30 days prior to surgery,
systemic sepsis within 48 h prior to surgery, ventilator depen-
dence, disseminated cancer, diabetes mellitus, hypertension
requiring medication, congestive heart failure 30 days prior
to surgery, dyspnea, current smoker within 1 year, history of
severe chronic obstructive pulmonary disease (COPD), dialy-
sis, acute renal failure, height, and weight. For patients with a
preoperative risk calculator factor missing, the risk was as-
sumed to be at the lowest risk level. The BSurgeon
Adjustment^ was set at B1 -No adjustment necessary^ for all
cases.
Data Analysis
Categorical variables were presented as frequencies and per-
centages; continuous variables were presented as medians and
interquartile ranges (IQR). The observed incidence of the var-
ied outcomes was compared among patients undergoing mi-
nor and major hepatectomy. In addition, the proportions of
observed outcomes were compared with the median-
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predicted risk according to the SRC. Concordance (C) statistic
and Brier score were evaluated to assess the predictive ability
of the SRC. The C-statistic represents the probability that an
individual with the outcome of interest will have a higher
predicted probability based on the logistic regression model
compared with an individual who did not have the
outcome.22,23 A C-statistic of 0.5 indicates random concor-
dance, while a value of 1.0 indicates a perfect predictive abil-
ity of the logistic regression model.22 The Brier score mea-
sures the accuracy of probabilistic predictions; a score of 0 is
associated with perfect predictive accuracy.24 Categorical var-
iables were compared using chi-square tests and Fisher exact
tests where appropriate. Continuous variables were compared
using the Wilcoxon rank-sum tests and Kruskal-Wallis one-
way analysis of variance. Logistic regression was utilized to
examine the correlation between observed outcomes and the
chance of outcome. Statistical significance was assessed at
α = 0.05. Analyses of Brier score were performed using
SAS v9.4. All other analyses were performed using SPSS,
version 25 (IBM Corp).
Results
Patient Characteristics and Postoperative Outcomes
A total of 500 patients who underwent curative-intent hepa-
tectomy for HCC were included in the analytic cohort
(Table 1). Overall, median age was 75 years old (IQR 72–
78) and the majority of patients were male (n = 367, 73.4%).
Roughly half of the patients were white (n = 229, 45.8%) and
the majority had an independent functional status (n = 414,
82.8%). The median Charlson comorbidity score index was
5 (IQR 2–6), while nearly half the patients were ASA class 2
(n = 237, 47.4%). Roughly one in three patients had cirrhosis
(n = 182, 37.6%). Most patients (n = 324, 64.8%) underwent a
minor hepatectomy, while roughly one-third of patients (n =
176, 35.2%) underwent a major hepatic resection (left
hepatectomy n = 49, 9.8%; right hepatectomy n = 90, 18%;
and trisegmentectomy n = 37, 7.4%). The vast majority of
patients had an elective operation (n = 460, 92%).
Following surgical resection (Table 2), roughly one in five
patients (21.4%) experienced a complication (minor hepatec-
tomy n = 50, 15.4% vs. major hepatectomy n = 57, 32.4%;
p < 0.001). Overall, the most common postoperative compli-
cations were SSI (n = 37, 7.5%), renal failure (n = 22, 4.4%),
and pneumonia (n = 17, 3.4%). Perhaps not surprising, com-
pared with individuals who underwent a minor hepatectomy, a
greater proportion of patients who underwent a major hepa-
tectomy experienced a serious complication (14.2% vs.
29.5%; p < 0.001). Similarly, the incidence of 30-day readmis-
sion (4.6% vs. 11.2%; p = 0.013) and reoperation (0.9% vs.
4.6%; p = 0.006) was higher among patients who underwent a
major hepatic resection compared with patients who
underwent a minor hepatic resection. Of note, the incidence
of 30-day mortality (0.9% vs. 2.3%; p = 0.250) and non-home
discharge (1.4% vs. 4.4%; p = 0.062) was similar among pa-
tients who underwent a minor versus major hepatectomy.
Surgical Risk Calculator Outcome
Table 3 summarizes the observed-event occurrence
(percentage) versus the median-predicted risk (median percent
predicted risk, IQR) among all patients for the various post-
operative outcomes of interest. Of note, the observed inci-
dence of VTE (3.2%) and renal failure (4.4%) exceeded the
median-predicted risk for these outcomes (VTE, 1.8%; IQR
1.5–3.1 and renal failure, 1.0%; IQR 0.5–2.0). In contrast, the
observed incidence of 30-day readmission (7.0%) and non-
home discharge (2.5%) was lower than the median-predicted
risk (30-day readmission, 9.4%; IQR 7.4–12.8 and non-home
discharge, 5.7%; IQR 3.3–11.7) (Table 3).
The NSQIP risk calculator was applied to all patients and
the C-statistic and Brier scores were calculated for all 12 sur-
gical outcomes (Table 4). Patients who experienced a serious
or any complication had a higher risk score approximately
Fig. 1 Analytical sample of the
patients included from the multi-
institutional international
database
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67% of the time (serious complication, 0.670; 95%CI 0.612–
0.730 and any complication, 0.671; 95%CI 0.609–0.731).
Model discrimination was weakest for VTE (C-statistic
0.538, 95%CI 0.378–0.698; Brier score, 0.077) and SSI (C-
statistic 0.566, 95%CI 0.466–0.666; Brier score 0.069).
Additionally, only 57.8% and 71.2% of patients who experi-
enced readmission (C-statistic 0.578, 95%CI 0.468–0.688) or
mortality (C-statistic 0.712, 95%CI 0.508–0.917) were cor-
rectly identified by the model. The SRC model was best at
predicting non-home discharge (C-statistic 0.781, 95%CI
0.718–0.844; Brier score 0.024), reoperation (C-statistic
0.775, 95%CI 0.647–0.904; Brier score 0.023), UTI (C-statis-
tic 0.764, 95%CI 0.659–0.868; Brier score 0.025), and pneu-
monia (C-statistic 0.722, 95%CI 0.598–0.845; Brier score
0.031). Receiver operating characteristic (ROC) curves were
defined and depicted for each complication type (Fig. 2).
Discussion
As patient outcomes become increasingly linked to provider
reimbursement, heightened emphasis has been placed on proper
patient risk stratification, as well as on adequate informed con-
sent. The Centers for Medicare and Medicaid services created
the Quality Improvement Organization in 2014 as a means to
improve the quality of care for Medicare beneficiaries with a
goal to decrease surgical complications.25 Surgeons should
therefore comprehensively assess surgical risk not only to in-
form patients of the expected perioperative course but also to
identify modifiable risk factors in hopes of improving patient
outcomes. Risk assessment or clinical prediction tools have
been developed to guide shared decision-making and define
Table 1 Demographics and patient characteristics
Variable Total, n (%)








Charlson comorbidity score index—median (IQR) 5 (2, 6)
Functional status
Independent 414 (82.8)










Partial hepatectomy 324 (64.8)
Left hepatectomy 49 (9.8)






Height—median (IQR) 166 (159–172)
Weight—median (IQR) 69 (59–80)






















































ASA, American Society of Anesthesiologist; AA, African American;
COPD, chronic obstructive pulmonary disease; IQR, interquartile range
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benchmark values for surgical outcomes.26 Tools such as the
ACSNSQIP SRC are typically derived using retrospective data
on routinely collected pre- and intraoperative factors. Previous
authors have evaluated the SRC’s performance to predict out-
comes after general surgery, emergency surgery, orthopedic
surgery, and gynecological surgery and have noted heteroge-
neous results.27–29 For example, Mogal et al. reported that the
SRC had a good ability to predict outcomes among patients
undergoing pancreaticoduodenectomy.30 In contrast, Beal
et al. noted that the actual proportion of patients experiencing
a complication was much higher than the median-predicted risk
for patients undergoing liver and pancreatic surgery.21
Therefore, the actual performance of SRC remains a topic of
debate. In addition, the performance of the SRC has not been
previously examined specifically among the elderly. As the risk
of complications may be very different among the elderly than
the general population, accurate preoperative risk assessment
among the aged population is critical. The current study was
important because it specifically sought to externally validate
and examine the accuracy of the ACS NSQIP SRC to predict
outcomes among elderly patients undergoing liver resection of
HCC using a large, multi-institutional international database.
Of note, the ACS NSQIP SRC failed to estimate accurately
the risk of many adverse outcomes after hepatectomy among
the elderly. Specifically, the incidence of renal failure and VTE
was underestimated by the SRC, while the calculator
overestimated the risk for 30-day readmission and non-home
discharge. Furthermore, the prediction model performed no
better than random chance at discriminating patients who expe-
rienced a SSI, VTE, readmission, and 30-day mortality.








Total 500 324 (64.8) 176 (35.2)
Serious complications 98 (19.6) 46 (14.2) 52 (29.5) < 0.001
Any complications 107 (21.4) 50 (15.4) 57 (32.4) < 0.001
Pneumonia 17 (3.4) 7 (2.2) 10 (5.7) 0.067
Cardiac complication 10 (2.0) 3 (0.9) 7 (4.0) 0.038
Surgical site infection 37 (7.5) 21 (6.5) 16 (9.1) 0.29
Urinary tract infection 13 (2.6) 5 (1.6) 8 (4.6) 0.073
Venous thromboembolism 16 (3.2) 9 (2.8) 7 (4.0) 0.60
Renal failure 22 (4.4) 12 (3.7) 10 (5.7) 0.36
30-day readmission 33 (7.0) 14 (4.6) 19 (11.2) 0.013
Reoperation 11 (2.4) 3 (0.9) 8 (4.6) 0.006
30-day mortality 7 (1.4) 3 (0.9) 4 (2.3) 0.250
Non-home discharge 11 (2.5) 4 (1.4) 7 (4.4) 0.062
Table 3 Observed incidence
versus predicted risk for
postoperative outcomes
Outcome All cases N = 500
Observed incidence % Predicted risk median % (IQR)
Serious complications 19.6 15.5 (11.2, 21.9)
Any complications 21.4 17.7 (13.1, 23.9)
Pneumonia 3.4 3.3 (1.7, 4.6)
Cardiac complication 2.0 1.3 (0.7, 2.6)
Surgical site infection 7.5 6.8 (5.1, 9.1)
Urinary tract infection 2.6 2.4 (1.9, 3.1)
Venous thromboembolism 3.2 1.8 (1.5, 3.1)
Renal failure 4.4 1.0 (0.5, 2.0)
30-day readmission 7.0 9.4 (7.4, 12.8)
Reoperation 2.4 2.2 (1.7, 3.4)
30-day mortality 1.4 0.8 (0.3, 2.2)
Non-home discharge 2.5 5.7 (3.3, 11.7)
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Fig. 2 Comparison of observed incidence of postoperative outcomes stratified by the risk categories of the risk calculator
Table 4 Discrimination (C-
statistics) of 12 outcomes All cases
Model C-
statistic
95%CI p Brier score
Serious complications 0.670 0.612–0.730 < 0.001 0.149
Any complications 0.671 0.609–0.731 < 0.001 0.159
Pneumonia 0.722 0.598–0.845 0.002 0.031
Cardiac complication 0.705 0.533–0.877 0.027 0.019
Surgical site infection 0.566 0.466–0.666 0.182 0.069
Urinary tract infection 0.764 0.659–0.868 0.001 0.025
Venous thromboembolism 0.538 0.378–0.698 0.601 0.077
Renal failure 0.682 0.554–0.811 0.004 0.077
Readmission 0.578 0.468–0.688 0.138 0.064
Reoperation 0.775 0.647–0.904 0.001 0.023
Mortality 0.712 0.508–0.917 0.054 0.014
Non-home discharge 0.781 0.718–0.844 0.001 0.024
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Together, the data suggest that the SRC was not a reliable tool
to estimate the risk of perioperative complications among the
elderly who were undergoing a hepatic resection for HCC.
Prognostication based on individual patient characteristics
may be a more helpful way to inform patients of their specific
peri- and postoperative risks. To this point, Kishida et al. noted
that elderly patients undergoing hepatectomy for HCC had a
greater likelihood of experiencing grade 3a or higher Clavien-
Dindo complications compared with younger patients.31 In
fact, the incidence of complications among the elderly has
been estimated to be as high as 50%, yet the range of risk
can vary considerably.31–33 For patients undergoing liver re-
section, the most common complications include SSI, deep-
space infection, UTI, bile leakage, and liver failure.34,35 The
ASC NSQIP SRC provided estimates on the risk for some of
the more common complications like SSI and UTI, yet data
from the current study demonstrated that the model performed
relatively poor. Specifically, among patients who experienced
a SSI, the SRC had correctly assigned these patients a higher
risk score only 56% of the time. Additionally, SRC routinely
overestimated the incidence of non-home discharge and read-
mission. In fact, the accuracy of the SRC to predict readmis-
sion among elderly patients was only slightly better than
chance (C-statistic, 0.578). Interestingly, Paredes et al. had
previously noted that, while elderly patients did not have an
increased risk of readmission comparedwith younger patients,
elderly patients had higher rates of non-index readmission.36
In turn, the poor performance of the SRC to predict readmis-
sion may be due to the fact that the SRC was derived from
NSQIP data, which were limited to the same hospital readmis-
sion within 30 days. Collectively, the data serve to highlight
the limitations of the SRC to stratify elderly patients with
regard to the risk of various complications—especially read-
mission—following resection of HCC.
While chronological age has been associated with out-
comes following hepatic resection, physiological age may be
more important in estimating the risk of postoperative
outcomes.8,37,38 In particular, some groups have suggested
that some measures of physiological fitness or frailty should
be incorporated into tools to predict morbidity and
mortality.32,36 To this end, the ACS NSQIP SRC accounted
for the functional status of the patient at the time of operation
with the Bdependence^ variable (i.e., independent, partially
dependent, totally dependent). This variable may not have
been adequate to capture the true physiological status of el-
derly patients and thereby have contributed to the general poor
performance of the SRC. Rather, Saraiva and colleagues have
reported that functional status defined according to metabolic
equivalents (METs) was a more powerful means to assess the
risk of surgical morbidity among elderly patients undergoing
cancer surgery.39 Studies from our group and others have also
suggested that frailty and sarcopenia may be indicative of a
patient’s physiologic age and consequentially serve as a better
predictor of postoperative outcomes.40–42 To this point,
Robinson et al. reported that geriatric assessment markers of
frailty, disability, and medical comorbidity were strongly as-
sociated with 6-month postoperative mortality and
postdischarge institutionalization following a major operation
among the elderly.43 While the SRC incorporated a number of
measures, the inability to better account for physiologic age,
frailty, and exercise tolerance among the elderly limited the
accuracy and applicability of the tool.
While the SRC tool did not provide an accurate means to
estimate the risk of morbidity among elderly patients under-
going hepatic resection for HCC, such tools may be important
to help guide practitioner and patient-level decision-making.44
The identification of patients at high risk of morbidity may
allow for preemptive intervention. For example, Landefeld
et al. reported that the implementation of a program consisting
of patient-centered care that emphasized independence/mobil-
ity, pro-active discharge planning, and intensive review of
predischarge medications improved the ability of older pa-
tients to be discharged at home rather than to long-term care
institutions.45 In a separate study, Carli and colleagues sug-
gested that a prehabilitation home-base program consisting of
strength and endurance exercises, as well as improvements in
nutritional status, could optimize elderly patients prior to sur-
gical intervention.46 Future risk estimation tools should aim to
better identify elderly patients at highest risk of postoperative
complications, non-home discharge, and readmission to target
these individuals for preoperative interventions such as
prehabilitation.
The current study had several limitations that need to be
considered when interpreting the data. Similar to other retro-
spective cohort studies, the data was subject to information
bias. While the ACS NSQIP data was collected by profession-
al coders that had undergone training to ensure the accuracy of
the documentation, data in the current study was collected by
clinicians. To limit possible information bias, definitions of
the variables based on ACS NSQIP were provided to ensure
adequate categorization. Though the multi-institutional nature
of the analytic cohort allowed for a Breal-word^ attempt at
validating the SRC using a diverse population, there exists a
possibility of institution practices affecting the results. In order
to limit this, most patients were recruited from major referral
centers given that the overwhelming majority of liver resec-
tions for HCC among the elderly are performed at tertiary
centers.47 Another limitation of the SRC itself was the lack
of specific factors related to liver function that may better
predict postoperative course (MELD score, INR, presence of
cirrhosis, etc.).
In conclusion, the current work provides important insight
regarding the use of the ACS NSQIP surgical risk calculator
among elderly patients undergoing hepatic resection for HCC.
Overall, the SRC performed poorly in this patient population.
Specifically, the SRC underestimated the risk of certain
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complications such as VTE and renal failure, while providing
no more than a Bchance^ estimation of other postoperative
outcomes such as readmission.While the SRC performed best
in estimating the risk of non-home discharge andmortality, the
model failed to explain 20–30% of the patient-level variabil-
ity. These data demonstrate that the ACS NSQIP SRC has
little clinical application in risk stratifying elderly patients be-
ing considered for hepatic resection of HCC. Future refine-
ment and development of better predictive tools to risk-stratify
outcomes among elderly patients undergoing resection of
HCC are warranted.
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